Citiranje zadetka

Citação APA (7ª ed.)
Deodhar, A., Mease, P. J., Kiltz, U., Gaffney, K., Marzo-Ortega, H., Dubreuil, M., . . . Prajapati, C. (2026). Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: Results from the BE MOBILE studies and their open-label extension. BMJ Publishing Group.
Citação do estilo Chicago (17ª ed.)
Deodhar, Atul, et al. Bimekizumab Treatment for Sustained Improvements in Patient Symptoms and Health-related Quality of Life to 3 Years in Axial Spondyloarthritis: Results from the BE MOBILE Studies and Their Open-label Extension. BMJ Publishing Group, 2026.
Citação MLA (9ª ed.)
Deodhar, Atul, et al. Bimekizumab Treatment for Sustained Improvements in Patient Symptoms and Health-related Quality of Life to 3 Years in Axial Spondyloarthritis: Results from the BE MOBILE Studies and Their Open-label Extension. BMJ Publishing Group, 2026.
Opozorilo: Ti citati niso vedno 100% točni.